PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Macleods Pharma UK Limited
MP

Macleods Pharma UK Limited

Billingham
SME

Macleods Pharma UK Limited is a global pharmaceutical company engaged in developing, manufacturing, and marketing a wide range of formulations across various therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment.

macleodspharma.com ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£103.4m
Live
13
Buyers
3
12m
£37.2m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts13 / 17
  • Top buyers3
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Macleods Pharma UK LimitedUpdated 06 Jul 2026

At a glance · for buyers and watchdogs

Macleods Pharma UK Limited has won £103.4m across 3 public-sector buyers, with 13 live contracts. No active Companies House risk flags.

Why: top buyer NHS England at 85% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
13 of 17Live contracts
85%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Services · 2
Research and DevelopmentFocus on the development of active pharmaceutical ingredients (APIs) and formulations, analytical development, and bioequivalence studies. ↗ManufacturingRobust manufacturing operations with a focus on hygiene and quality standards to meet regulatory requirements. ↗

Extracted automatically from macleodspharma.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 13 live · 4 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
NHS National Generic Pharmaceuticals - Wave 15c
NHS England—01 Jun 2026£37.2m16 mopending
NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products
NHS England3360000001 Jun 2025£376k2 yrsLive
NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024
NHS England3360000001 Nov 2024£48.2m2 yrsLive
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)
NHS England3360000001 Jun 2024£0.023 yrsLive
NHS National Generic Pharmaceuticals Wave 14a
NHS England3360000001 Feb 2023£2.1m2 yrsClosed
National Procurement for HIV and Preventative Treatments
NHSE&I3360000001 Feb 2022£15.3m1.5 yrsClosed
NHS National Generic Pharmaceuticals Interim 2
NHS England3369000001 Feb 2021£242k13 moClosed
NHS National Generic Pharmaceuticals - Wave 15c
NHS England————Live
NHS National Generic Pharmaceuticals Interim 2 2020
The NHS Commissioning Board (operating under the name of NHS England)33690000———Live
NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025
NHS England33600000———Live
Total live value £48.6m · mean award £6.1m1–10 of 17

Top buyers · 3 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
14 contracts
85%
since 2020
2
NHSE&I
1 contract
15%
since 2022
3
The NHS Commissioning Board (operating under the name of NHS England)
2 contracts
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire14 contracts
100%
North West2 contracts
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Macleods Pharma UK Limited highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m22
JA
Janssen-Cilag Ltd
Yes£117.6m18
AB
AbbVie Ltd
Yes£95.2m12
TA
Thornton and Ross Ltd
Yes£72.5m12
AC
ACCORD-UK LTD
Yes£71.2m21
MP
Macleods Pharma UK Limited
Yes£37.2m—
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Mar 2025
Confirmation statement
Up to date
Next due 31 Dec 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
06455382
Status
Active
Type
Private limited
Incorporated
17 Dec 2007
Reg. office
Wynyard Park House Wynyard Avenue, Wynyard, Billingham, TS22 5TB
SIC codes
21100
Last accounts
31 Mar 2025
Next accounts due
31 Dec 2026

Directors & PSC

  • AGARWAL, Vijay — director
    Appointed 17 Dec 2007
  • Mr Vijay Agarwal — person with significant control
    significant influence or control

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
MACLEODS PHARMA UK LIMITED
06455382 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.